Back
The Allstate Corp. 10K Form
Buy
58
ALL
The Allstate Corp.
Last Price:
$207.57
Seasonality Move:
5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-21 | 10K | ALL/The Allstate Corp. Annual |
| 2023-11-01 | 10Q | ALL/The Allstate Corp. Quarterly |
| 2023-08-01 | 10Q | ALL/The Allstate Corp. Quarterly |
| 2023-05-03 | 10Q | ALL/The Allstate Corp. Quarterly |
| 2023-02-16 | 10K | ALL/The Allstate Corp. Annual |
| 2022-11-02 | 10Q | ALL/The Allstate Corp. Quarterly |
Receive ALL News And Ratings
See the #1 stock for the next 7 days that we like better than ALL
ALL Financial Statistics
Sales & Book Value
| Annual Sales: | $64.7B |
|---|---|
| Cash Flow: | $3.2B |
| Price / Cash Flow: | 6.43 |
| Annual Sales: | $110.03 |
| Price / Book: | 1.89 |
Profitability
| EPS (TTM): | 38.18590 |
|---|---|
| Net Income (TTM): | $10.3B |
| Gross Margin: | $0 |
| Return on Equity: | 40.9% |
| Return on Assets: | 9.54% |
The Allstate Corp. Earnings Forecast
Key The Allstate Corp. Financial Ratios
-
The Gross Profit Margin over the past 34 years for ALL is 0.00%.
-
The Selling, General & Administrative Expenses for ALL have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 3.89% of Operating Income.
-
The Net Earning history of ALL is 15.86% of Total Revenues.
-
Per Share Earnings over the last 34 years have been positive in 21 years.
The Allstate Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | ALL |
| CUSIP: | 020002 |
| Website: | allstate.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 0.4 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.45 |
|---|---|
| Forward P/E Ratio: | 8.25 |
ALL Technical Analysis vs Fundamental Analysis
Buy
58
The Allstate Corp. (ALL)
is a Buy
Is The Allstate Corp. a Buy or a Sell?
-
The Allstate Corp. stock is rated a BuyThe current The Allstate Corp. [ALL] share price is $207.51. The Score for ALL is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.